Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report
Abstract Background Immune checkpoint inhibitors (ICIs) are the treatment of choice for several cancers and can be associated with remarkable clinical benefit, but can also cause serious immune-related adverse events (irAEs). Management of rare and severe irAEs is challenged by an incomplete knowled...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2018-08-01
|
| Saila: | Journal for ImmunoTherapy of Cancer |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s40425-018-0396-9 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|